Aug 17, 2026 | Industry Trends, Market Scan, New Technology
The Obesity Drug Pipeline in 2026 Obesity drug development is expanding rapidly beyond the first generation of GLP-1 therapies. More than 1 billion people worldwide were living with obesity in 2022, including approximately 890 million adults. The clinical and...
Mar 31, 2026 | Data Analytics, New Technology
Artificial intelligence has become a fixture in pharmaceutical strategy conversations. Nearly every major organization has invested in it in some form, whether through internal teams, external partnerships, or acquisitions. The expectation is clear: AI should...
Feb 28, 2026 | Data Analytics, Industry Trends, Market Scan, New Technology
Examining the innovation-to-risk balance among the pharmaceutical industry’s top companies In our previous post, we evaluated the pharmaceutical industry’s leading companies in terms of overall R&D pipeline strength, resulting in Roche, AstraZeneca, Bristol-Myers...
Jan 16, 2026 | New Technology, Probability of Success
Unlocking Next-Gen POS Forecasting for Biopharma Success In the high-stakes world of biopharma, advanced Probability of Success (POS) forecasting can revolutionize the landscape of clinical trials. By adopting next-gen POS forecasting models, companies can...
Nov 9, 2025 | New Technology, Probability of Success
Redefining Probability of Success in Pharma: A Data-Driven Revolution In the world of pharmaceutical strategic planning and analytics, traditional Probability of Success (POS) forecasts are a familiar, yet often frustrating approach to assessing clinical risk. While...
Oct 26, 2025 | Business, Data Analytics, Industry Trends, Market Scan, New Technology, Probability of Success
The leaders, the contenders, and the strategies for success As we approach the 4th quarter of 2025, let’s review where the pharmaceutical industry’s leading companies rank in terms of overall pipeline strength. Roche, AstraZeneca, and Bristol-Myers Squibb sit in a...
